LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

Search

Envista Holdings Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

19.62 -2.58

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

19.4

Max

20.25

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-57M

-30M

Pardavimai

-12M

670M

P/E

Sektoriaus vid.

222.778

105.69

Pelnas, tenkantis vienai akcijai

0.32

Pelno marža

-4.523

Darbuotojai

12,300

EBITDA

9.6M

88M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+11.23% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-87M

3.3B

Ankstesnė atidarymo kaina

22.2

Ankstesnė uždarymo kaina

19.62

Naujienos nuotaikos

By Acuity

50%

50%

171 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Envista Holdings Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-13 21:34; UTC

Uždarbis

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

2025-11-13 23:45; UTC

Rinkos pokalbiai

Nikkei May Fall After Wall Street's Weakness -- Market Talk

2025-11-13 23:42; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

2025-11-13 23:41; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Dip-Buying -- Market Talk

2025-11-13 23:24; UTC

Uždarbis

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

2025-11-13 23:24; UTC

Uždarbis

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

2025-11-13 23:23; UTC

Uždarbis

JBS NV 3Q EPS 52c >JBS

2025-11-13 23:23; UTC

Uždarbis

JBS NV 3Q Sales $22.6B >JBS

2025-11-13 23:04; UTC

Rinkos pokalbiai

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

2025-11-13 22:02; UTC

Uždarbis

Nu Holdings 3Q Net $783M >NU

2025-11-13 22:01; UTC

Uždarbis

Nu Holdings 3Q Rev $4.2B >NU

2025-11-13 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

2025-11-13 21:50; UTC

Uždarbis

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

2025-11-13 21:45; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

2025-11-13 21:41; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

2025-11-13 21:33; UTC

Rinkos pokalbiai

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

2025-11-13 21:33; UTC

Uždarbis

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

2025-11-13 21:31; UTC

Uždarbis

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

2025-11-13 21:25; UTC

Uždarbis

Figure Tech Solutions 3Q Rev $156.4M >FIGR

2025-11-13 21:25; UTC

Uždarbis

Figure Tech Solutions 3Q EPS 34c >FIGR

2025-11-13 21:23; UTC

Uždarbis

Intchains Group 3Q Rev $1.3M >ICG

2025-11-13 21:03; UTC

Uždarbis

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

2025-11-13 21:02; UTC

Uždarbis

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

2025-11-13 21:01; UTC

Uždarbis

Applied Materials 4Q Rev $6.8B >AMAT

2025-11-13 21:01; UTC

Uždarbis

Applied Materials 4Q Gross Margin 48.0% >AMAT

Akcijų palyginimas

Kainos pokytis

Envista Holdings Corp Prognozė

Kainos tikslas

By TipRanks

11.23% į viršų

12 mėnesių prognozė

Vidutinis 22.38 USD  11.23%

Aukščiausias 27 USD

Žemiausias 18 USD

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Envista Holdings Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

11 ratings

4

Pirkti

6

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

15.98 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

171 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
help-icon Live chat